MedTrace Logo

The Efficacy of A New Crosslinked Hyaluronan Gel in Prevention of Intrauterine Adhesion

NCT03353909 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2017-11-27

No results posted yet for this study

Summary

Using American Fertility Society classification of intrauterine adhesions, the efficacy of a new crosslinked hyaluronan gel in reducing intrauterine adhesion formation after dilatation and curettage for delayed miscarriage in women without previous dilatation and curettage was examined.

Conditions

  • Intrauterine Adhesion

Interventions

DEVICE

new crosslinked hyaluronan gel

At the end of the dilatation and curettage, new crosslinked hyaluronan gel was applied to the uterine cavity.

Sponsors & Collaborators

  • BioRegen Biomedical (CHangzhou) Co., Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2017-02-15
Completion
2017-02-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03353909 on ClinicalTrials.gov